首页> 外文期刊>OncoTargets and therapy >Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report
【24h】

Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report

机译:Endostar和传统化学疗法成功治疗复发性睾丸胚胎横纹肌肉瘤:一例

获取原文
           

摘要

Embryonal rhabdomyosarcoma (ERMS) has a low prevalence, poor prognosis, and limited treatment efficacy. We report a case of an 18-year-old male whose disease relapsed in the abdominal cavity after a testicular ERMS curative resection. The patient received eight sequential cycles of rescue therapy using cisplatin and isocyclophosphamide in combination with a vascular targeted drug, Endostar. The therapeutic effect of the combination regimen has been evaluated for complete response. This is the first case to report using Endostar and chemotherapy in relapsed ERMS, and the curative effect results in complete response. Endostar, a new vascular targeted drug, combined with chemotherapy may play a synergistic role and provide a reference for the treatment of ERMS.
机译:胚胎性横纹肌肉瘤(ERMS)患病率低,预后差且治疗效果有限。我们报告了一例18岁男性,其疾病在睾丸ERMS根治性切除后在腹腔复发。该患者接受顺铂和异环磷酰胺联合血管靶向药物Endostar的八个连续救援治疗周期。已经评估了联合方案的治疗效果以获得完全缓解。这是第一例报告使用Endostar和化学疗法治疗复发性ERMS的病例,其疗效可导致完全缓解。 Endostar是一种新型的血管靶向药物,与化学疗法联合使用可能起协同作用,为ERMS的治疗提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号